Literature DB >> 22135466

Mechanistic modeling of the effects of myoferlin on tumor cell invasion.

Marisa C Eisenberg1, Yangjin Kim, Ruth Li, William E Ackerman, Douglas A Kniss, Avner Friedman.   

Abstract

Myoferlin (MYOF) is a member of the evolutionarily conserved ferlin family of proteins, noted for their role in a variety of membrane processes, including endocytosis, repair, and vesicular transport. Notably, ferlins are implicated in Caenorhabditis elegans sperm motility (Fer-1), mammalian skeletal muscle development and repair (MYOF and dysferlin), and presynaptic transmission in the auditory system (otoferlin). In this paper, we demonstrate that MYOF plays a previously unrecognized role in cancer cell invasion, using a combination of mathematical modeling and in vitro experiments. Using a real-time impedance-based invasion assay (xCELLigence), we have shown that lentiviral-based knockdown of MYOF significantly reduced invasion of MDA-MB-231 breast cancer cells in Matrigel bioassays. Based on these experimental data, we developed a partial differential equation model of MYOF effects on cancer cell invasion, which we used to generate mechanistic hypotheses. The mathematical model predictions revealed that matrix metalloproteinases (MMPs) may play a key role in modulating this invasive property, which was supported by experimental data using quantitative RT-PCR screens. These results suggest that MYOF may be a promising target for biomarkers or drug target for metastatic cancer diagnosis and therapy, perhaps mediated through MMPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135466      PMCID: PMC3250187          DOI: 10.1073/pnas.1116327108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Fractional step methods applied to a chemotaxis model.

Authors:  R Tyson; L G Stern; R J LeVeque
Journal:  J Math Biol       Date:  2000-11       Impact factor: 2.259

Review 2.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

3.  Extracellular matrix and tenascin-C in pathogenesis of breast cancer.

Authors:  P L Jones
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

4.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Extracellular matrix concentration exerts selection pressure on invasive cells.

Authors:  A J Perumpanani; H M Byrne
Journal:  Eur J Cancer       Date:  1999-08       Impact factor: 9.162

6.  Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains.

Authors:  Dawn Belt Davis; Katherine R Doherty; Anthony J Delmonte; Elizabeth M McNally
Journal:  J Biol Chem       Date:  2002-04-16       Impact factor: 5.157

7.  Myoferlin gene silencing decreases Tie-2 expression in vitro and angiogenesis in vivo.

Authors:  Carol Yu; Arpeeta Sharma; Andy Trane; Soraya Utokaparch; Cleo Leung; Pascal Bernatchez
Journal:  Vascul Pharmacol       Date:  2011-05-06       Impact factor: 5.773

8.  Myoferlin, a candidate gene and potential modifier of muscular dystrophy.

Authors:  D B Davis; A J Delmonte; C T Ly; E M McNally
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

9.  Interaction of tumor with its micro-environment: A mathematical model.

Authors:  Yangjin Kim; Avner Friedman
Journal:  Bull Math Biol       Date:  2009-11-12       Impact factor: 1.758

10.  Transformed epithelial cells and fibroblasts/myofibroblasts interaction in breast tumor: a mathematical model and experiments.

Authors:  Yangjin Kim; Julie Wallace; Fu Li; Michael Ostrowski; Avner Friedman
Journal:  J Math Biol       Date:  2009-11-10       Impact factor: 2.259

View more
  43 in total

1.  Enzymatic cleavage of myoferlin releases a dual C2-domain module linked to ERK signalling.

Authors:  Ann-Katrin Piper; Samuel E Ross; Gregory M Redpath; Frances A Lemckert; Natalie Woolger; Adam Bournazos; Peter A Greer; Roger B Sutton; Sandra T Cooper
Journal:  Cell Signal       Date:  2017-02-10       Impact factor: 4.315

2.  Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo.

Authors:  Jessica K Simmons; Wessel P Dirksen; Blake E Hildreth; Carlee Dorr; Christina Williams; Rachael Thomas; Matthew Breen; Ramiro E Toribio; Thomas J Rosol
Journal:  Prostate       Date:  2014-07-07       Impact factor: 4.104

3.  Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.

Authors:  Jessica Wagner; Christina Leah Kline; Marie D Ralff; Avital Lev; Amriti Lulla; Lanlan Zhou; Gary L Olson; Bhaskara Rao Nallaganchu; Cyril H Benes; Joshua E Allen; Varun V Prabhu; Martin Stogniew; Wolfgang Oster; Wafik S El-Deiry
Journal:  Cell Cycle       Date:  2017-05-10       Impact factor: 4.534

4.  Canine prostatic cancer cell line (LuMa) with osteoblastic bone metastasis.

Authors:  Said M Elshafae; Wessel P Dirksen; Aylin Alasonyalilar-Demirer; Justin Breitbach; Shiyu Yuan; Noriko Kantake; Wachiraphan Supsavhad; Bardes B Hassan; Zayed Attia; Lucas B Alstadt; Thomas J Rosol
Journal:  Prostate       Date:  2020-04-29       Impact factor: 4.104

5.  Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.

Authors:  Jessica Wagner; C Leah Kline; Lanlan Zhou; Kerry S Campbell; Alexander W MacFarlane; Anthony J Olszanski; Kathy Q Cai; Harvey H Hensley; Eric A Ross; Marie D Ralff; Andrew Zloza; Charles B Chesson; Jenna H Newman; Howard Kaufman; Joseph Bertino; Mark Stein; Wafik S El-Deiry
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

6.  The C2 domains of otoferlin, dysferlin, and myoferlin alter the packing of lipid bilayers.

Authors:  Naomi J Marty; Chelsea L Holman; Nazish Abdullah; Colin P Johnson
Journal:  Biochemistry       Date:  2013-08-06       Impact factor: 3.162

7.  Expression Profiling of a Human Thyroid Cell Line Stably Expressing the BRAFV600E Mutation.

Authors:  Byoung-Ae Kim; Hyeon-Gun Jee; Jin Wook Yi; Su-Jin Kim; Young Jun Chai; June Young Choi; Kyu Eun Lee
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

8.  The Role of the Tumor Microenvironment in Glioblastoma: A Mathematical Model.

Authors:  Yangjin Kim; Hyejin Jeon; Hans Othmer
Journal:  IEEE Trans Biomed Eng       Date:  2016-12-08       Impact factor: 4.538

9.  Inter-cellular signaling network reveals a mechanistic transition in tumor microenvironment.

Authors:  Yu Wu; Lana X Garmire; Rong Fan
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

10.  Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR.

Authors:  Miguel Vizoso; Humberto J Ferreira; Paula Lopez-Serra; F Javier Carmona; Anna Martínez-Cardús; Maria Romina Girotti; Alberto Villanueva; Sonia Guil; Catia Moutinho; Julia Liz; Anna Portela; Holger Heyn; Sebastian Moran; August Vidal; Maria Martinez-Iniesta; Jose L Manzano; Maria Teresa Fernandez-Figueras; Elena Elez; Eva Muñoz-Couselo; Rafael Botella-Estrada; Alfonso Berrocal; Fredrik Pontén; Joost van den Oord; William M Gallagher; Dennie T Frederick; Keith T Flaherty; Ultan McDermott; Paul Lorigan; Richard Marais; Manel Esteller
Journal:  Nat Med       Date:  2015-06-01       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.